Cargando…
A Novel Successful Case of Nasal and Sinus Yolk Sac Tumor With SMARCB1 (INI-1) Deficiency: A Case Report
Yolk sac tumors (YSTs) of the head and neck region account for only 1% of all malignant tumors of germ cell origin. YSTs with SMARCB1 deficiency are very aggressive. Only one nasal and sinus YST with SMARCB1-deficient carcinoma (SDC) was reported with follow-up information but the patient died 20 mo...
Autores principales: | He, Tianyu, Wang, Zhiyu, Su, Hongbo, Li, Sihan, He, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737640/ https://www.ncbi.nlm.nih.gov/pubmed/36514645 http://dx.doi.org/10.7759/cureus.31320 |
Ejemplares similares
-
Case Report: SMARCB1 (INI-1)-Deficient Carcinoma of the Nasal Cavity with Pure Yolk Sac Tumor Differentiation and Elevated Serum AFP Levels
por: Li, Chun-Yu, et al.
Publicado: (2021) -
Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1/INI-1 deficiency in a vulvar yolk sac tumor
por: Wei, Christina H., et al.
Publicado: (2023) -
SMARCB1/INI1-deficient tumors of adulthood
por: Parker, Nathaniel A., et al.
Publicado: (2020) -
Oncogenic roles of SMARCB1/INI1 and its deficient tumors
por: Kohashi, Kenichi, et al.
Publicado: (2017) -
SMARCB1(INI-1)-Deficient Sinonasal Carcinoma: An Evolving Entity
por: Chung, Sei Y., et al.
Publicado: (2023)